New Insights on Mt. Etna's Crust and Relationship with the Regional Tectonic Framework from Joint Active and Passive P-Wave Seismic Tomography.

In the Central Mediterranean region, the production of chemically diverse volcanic products (e.g., those from Mt. Etna and the Aeolian Islands archipelago) testifies to the complexity of the tectonic and geodynamic setting. Despite the large number of studies that have focused on this area, the relationships among volcanism, tectonics, magma ascent, and geodynamic processes remain poorly understood. We present a tomographic inversion of P-wave velocity using active and passive sources. Seismic signals were recorded using both temporary on-land and ocean bottom seismometers and data from a permanent local seismic network consisting of 267 seismic stations. Active seismic signals were generated using air gun shots mounted on the Spanish Oceanographic Vessel 'Sarmiento de Gamboa'. Passive seismic sources were obtained from 452 local earthquakes recorded over a 4-month period. In total, 184,797 active P-phase and 11,802 passive P-phase first arrivals were inverted to provide three different velocity models. Our results include the first crustal seismic active tomography for the northern Sicily area, including the Peloritan-southern Calabria region and both the Mt. Etna and Aeolian volcanic environments. The tomographic images provide a detailed and complete regional seismotectonic framework and highlight a spatially heterogeneous tectonic regime, which is consistent with and extends the findings of previous models. One of our most significant results was a tomographic map extending to 14 km depth showing a discontinuity striking roughly NW-SE, extending from the Gulf of Patti to the Ionian Sea, south-east of Capo Taormina, corresponding to the Aeolian-Tindari-Letojanni fault system, a regional deformation belt. Moreover, for the first time, we observed a high-velocity anomaly located in the south-eastern sector of the Mt. Etna region, offshore of the Timpe area, which is compatible with the plumbing system of an ancient shield volcano located offshore of Mt. Etna.

Novel bronchoscopic treatment for bronchopleural fistula using adipose-derived stromal cells.

BACKGROUND AIMS: In this report, we describe the successful bronchoscopic management of bronchopleural fistula in two patients, using autologous adipose-derived stromal cells. Cell therapy was considered for 2 cases of bronchopleural fistula refractory to conventional surgical treatment after control of the primary disease was confirmed and active pleural infection was ruled out. Briefly, adipose-derived stem cells were first isolated from lipoaspirate and used without cell expansion. In 24 months, we have not received more patients with bronchopleural fistula in our hospital and we have not been able to include more patients. METHODS: Briefly, adipose-derived stem cells were first isolated from lipo-aspirate and used without cell expansion. A bronchopleural fistula was identified through bronchoscopy, and the mucosa surrounding the fistula was ablated with an argon plasma coagulator. Isolated stem cells were then endoscopically injected into the de-epithelialized area and fistulous tract. If an open thoracostomy was present at the time of the intervention, the same procedure was performed on the pleural side. Bronchoscopic follow-up was scheduled weekly during the first month, monthly during the first year, and then yearly. The underlying etiologies were left pneumonectomy and right lower video-assisted lobectomy for non-small-cell lung cancer. The sizes of the fistulas were 6 mm and 3 mm in diameter, respectively. RESULTS: Both patients were discharged on the first postoperative day. The 3-year follow-up revealed a successful and maintained fistula closure, no treatment-related adverse reactions, nonlocal malignant recurrence and improved quality of life. CONCLUSIONS: This preliminary study showed that bronchoscopic application of autologous adipose-derived stem cells is a feasible, safe and effective procedure for treating bronchopleural fistula.

Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.

BACKGROUND: 1alpha,25-Dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] and its analogues inhibit growth of various types of cancer cells. Although the therapeutic potential of 1,25(OH)(2)D(3) is limited by its tendency to induce hypercalcemia, analogues such as EB1089 are potent inhibitors of cell growth and exhibit reduced calcemic effects. We analyzed the antiproliferative and calcemic effects of EB1089 in tissue culture and animal models of head and neck squamous cell carcinoma (SCC) to investigate its potential as a chemotherapeutic/chemopreventive agent. METHODS: The effects of 1,25(OH)(2)D(3) and EB1089 on cell growth and expression of p21(WAF1/CIP1) and p27(KIP1), which encode cyclin-dependent kinase inhibitors, and a novel target, gadd45alpha, a growth-arrest and DNA-damage gene, were monitored in cultured murine AT-84 SCC cells. The effects of these agents on AT-84 cell growth in vitro and on growth of AT-84 tumors in syngeneic C3H mice were monitored; treatment started at the time of tumor implantation (early tumor model) or after 12 days (late tumor model). Weight and serum calcium levels were also monitored in these animals. All P values were two-sided. RESULTS: Both 1,25(OH)(2)D(3) and EB1089 arrested proliferation of AT-84 cells in G(0)/G(1) phase, inhibited p21(WAF1/CIP1) expression, and induced expression of p27(KIP1) protein. 1,25(OH)(2)D(3) also enhanced the expression of gadd45alpha, apparently by a p53-independent mechanism. There was a statistically significant decrease in tumor growth for 1,25(OH)(2)D(3)-treated mice (P<.001 for early tumor model) and EB1089-treated mice (P<.001 and P =.001 for early and late tumor models, respectively). Unlike 1,25(OH)(2)D(3), EB1089 did not induce cachexia or hypercalcemia. The effects of 1,25(OH)(2)D(3) and EB1089 on expression of p21(WAF1/CIP1) and GADD45alpha were similar in tumors and in vitro. CONCLUSIONS: EB1089 completely inhibited growth of AT-84 SCC cells at nanomolar concentrations, reduced tumor growth, and did not have calcemic effects. Our results support continued investigation of EB1089 as a chemopreventive/chemotherapeutic agent for head and neck SCC.

A preliminary study on the usefulness of huIL-8 in cervical relaxation of the ewe for artificial insemination and for embryo transfer.

The efficacy of using human interleukin 8 (huIL-8) as an agent for inducing cervical relaxation in estrous and diestrous sheep was assessed in a small pilot study. Multiparous, estrus-synchronized ewes were treated for either 2 or 5 consecutive days with vaginal suppositories with or without 5 micrograms cytokine. Cervical penetration with an insemination instrument was then assessed in vivo. After euthanasia, physical, histological and enzymological properties of the cervix were examined. Treatment of diestrous sheep with huIL-8 did not result in recruitment of neutrophils into the cervix. Treatment of estrous sheep with huIL-8 usually led to neutrophil recruitment to the cervix and to either full or partial penetration of the cervix. However, some animals receiving placebo treatment had neutrophil infiltration of both the vagina and cervix and, in one of these, partial penetration of the cervix was also achieved. Thus, treatment with IL-8 as the sole agent in the vaginal suppository was not sufficient to relax the cervix of the nonpregnant ewe in this study.

Frameless stereotaxy in children.

Frameless stereotaxy provides stereotactic localization without a standard stereotactic frame. Other reference points on the patient are linked to radiographic images by means of a three-dimensional (3D) digitizer. We report the use of a frameless stereotactic system to assist in 53 procedures in 52 children using the ISG Viewing Wand system (ISG Technologies, Missasauga, Ont.). This device uses surface landmarks as well as random surface points as the reference system. The three-dimensional digitizer consists of a six-jointed articulated arm to which pointers, a rigid ventriculoscope, or stereotactic biopsy probe guide can be attached. Image reconstruction is performed on standard CT or MRI (3D volume acquisition) images, with typically 3-mm slice thickness. The tip of the probe can be displayed on 3D surfaced objects which can be cut away to reveal reformatted gray scale displayed on the cut surface, or in a triorthogonal view where simultaneous reformatted coronal and sagital views at the level of the tip of the probe are displayed. Cases for which the viewing wand was used included craniotomies for tumor (30), vascular malformation (6), epilepsy surgery (5), other lesions (3), rigid ventriculoscopy (9), and stereotactic biopsy (2). The accuracy of the system was measured by placing 20 fiducial markers on a plastic head of which 3-mm thickness CT images had been made. The average error using 4 fiducials as reference points was 1.5 mm when the fiducials were distributed around the circumference of the head. Using random surface points of 10, 20 and 40 in number gave average errors of 2.3, 1.6, 1.5 mm, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)